Applied Clinical Trials Magazine

10/31/2025

Accelerating Site Payments with Agentic AI: See it in Action

Unlock the future of clinical trial payments with CTFS Site Payments—an agentic AI driven, unified solution that accelerates payment cycles, boosts site satisfaction, and ensures global compliance.

Register now: https://hubs.li/Q03QKN1w0

10/29/2025

The Future Landscape of Schizophrenia Research

Mon, Nov 17, 2025 11:00 AM EST

Register Now: https://hubs.li/Q03Q2GFq0

10/23/2025

Overcoming Recruitment and Retention Barriers in Alzheimer’s and Dementia Studies

Discover proven strategies to overcome recruitment and retention challenges in Alzheimer’s and dementia trials. Gain actionable insights to boost enrollment, engage participants, and improve trial outcomes.

Register Now: https://hubs.li/Q03MLQ450

10/16/2025

Overcoming Recruitment and Retention Barriers in Alzheimer’s and Dementia Studies

Discover proven strategies to overcome recruitment and retention challenges in Alzheimer’s and dementia trials. Gain actionable insights to boost enrollment, engage participants, and improve trial outcomes.

Register Now: https://hubs.li/Q03MLH6w0

05/30/2025

\Mark Rodgers discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access

Download podcast and Q&A: https://hubs.li/Q03pkFK10

09/12/2024

Compliance with diverse clinical trial payment and data standards requires specialized skills.

09/12/2024

An overview of the advantages of implementing AI into clinical development and the obstacles that prevent its widespread adoption.

09/11/2024

📍2024 Veeva Systems R&D and Quality Summit Coverage
Dee DeOliviera, senior director, global regulatory operations, Cerevel Therapeutics (now part of AbbVie) highlights her experience in operations and how to address increased oversight from regulators

DeOliviera, senior director, global regulatory operations, Cerevel (now part of AbbVie) highlights her experience in regulatory operations and how to address increased oversight from regulators.